How to Read a Peptide COA

What a COA Actually Is

Here is the key idea before we get into specifics. A COA is only as good as the lab behind it and the paper trail that connects it to your vial. A polished PDF proves nothing on its own, because in the research-chemical world there is no auditing body and no requirement to produce a COA at all. So the goal is not to be impressed by a report. The goal is to verify it.

The 60-Second Read

If you only have a minute, here are the six things to check, in order. The rest of this guide explains each one in depth.

Identity: Is It the Right Molecule

Identity testing confirms the vial contains the peptide on the label and not something close to it. The workhorse method is mass spectrometry (often written MS, LC-MS, or ESI-MS), which measures the molecular weight of the peptide and compares it to the known value for that sequence. Modern instruments are extremely precise, so a result within roughly one mass unit (1 Da) of the published weight is the expected pass. You may also see amino acid analysis or peptide mapping, which confirm the actual sequence rather than just the total mass.

Purity: What HPLC % Really Means

HPLC purity is the number most people look at first. High-performance liquid chromatography separates the target peptide from related impurities such as truncated chains, deletion sequences, and synthesis byproducts, then reports the target peak as a percentage of the total area under the curve. A purity of 98% means 98% of the peptide material is the intended molecule and 2% is impurities. For most research peptides, 98% is the working minimum and 99% is preferred.

Two things to understand about that percentage. First, it is an area measurement on a chromatogram, not a measure of how much of the vial is peptide. Second, the method matters: a purity figure with no stated HPLC method is a number without a source. A real result looks slightly messy in a reassuring way. One tall, sharp peak for the target, a few small satellite peaks, and a little baseline noise. A chromatogram that is impossibly clean, with a flat baseline and no minor peaks at all, is a sign of fabrication, not perfection.

The Number Everyone Misreads

Peptide powder is never pure peptide. It also contains bound water and a counterion salt left over from purification. Peptides are hygroscopic, meaning they pull moisture from the air, and their basic residues bind salt. So even a peptide that is 99% pure by HPLC is typically only 60 to 90 percent peptide by weight. The rest is water and salt that you paid for at peptide prices. Net peptide content, measured by amino acid analysis, elemental analysis, or UV, is the number that tells you how much active material is really in the vial.

A COA that proudly reports purity but omits net peptide content is letting you do the convenient math in your head: assume the vial is nearly all peptide. It usually is not. This is also why two products with identical "99% pure" labels can deliver meaningfully different doses. The honest report shows both numbers.

Counterion, water, and residual solvents

A thorough COA also names the salt form. After purification, peptides are commonly isolated as a trifluoroacetate (TFA) salt. For material intended for people, the standard is to exchange that for an acetate salt, because acetate is the counterion used in the large majority of human-use peptide products. You may also see a water content figure from Karl Fischer titration and a residual solvents result. Low numbers here are good, and their presence at all signals a lab that tested the things that affect both dose and tolerability.

Sterility and Endotoxin

Here is the section that matters most for anything you inject, and the section research-chemical COAs almost always leave out. Purity tells you the molecule is right. It tells you nothing about whether the vial is contaminated. Two separate tests cover that.

Sterile preparation itself is governed by USP General Chapter <797>, the standard for sterile compounding environments. The practical takeaway is simple. If a COA for something meant to be injected does not show an explicit sterility pass and an endotoxin result under the limit, the two tests that protect you from infection and pyrogenic reactions were not done. That is not a paperwork gap. It is the core reason that injecting material sold "for research use only" is unsafe, regardless of how high the purity number is.

United States Pharmacopeia. General Chapter <71> Sterility Tests; General Chapter <85> Bacterial Endotoxins Test; General Chapter <797> Pharmaceutical Compounding, Sterile Preparations. View study

Lot Numbers and Who Ran the Test

Provenance is what ties the report to reality. Three things establish it. A lot or batch number that matches the vial label exactly, so the COA describes the material you actually received and not a different batch. Dates, including when the analysis was run and when the material expires or should be retested. And the identity of the testing lab, ideally an independent third party with recognized accreditation rather than the seller testing its own product.

How to Spot a Fake COA

Pulling it together, here is the red-flag list. Any one of these is a reason to be cautious. Several together mean the document is decorative.

One framing worth keeping in mind. Because no regulator audits research-chemical COAs, a fabricated report only needs to look right. That inverts the usual instinct. The more a COA leans on visual polish and the less it offers in verifiable provenance (named lab, matching lot, real dates, the unglamorous sterility and endotoxin lines), the less it should reassure you.

What a Prescription COA Shows

There is a structural reason a prescription compounded peptide comes with a real COA and a gray-market vial may not. Under section 503A of the federal Food, Drug, and Cosmetic Act, a compounding pharmacy may only use a bulk drug substance that is accompanied by a valid certificate of analysis and was made by a facility registered with the FDA. The obligation is legal, not optional. A research-chemical seller operates under no equivalent requirement, which is why "research use only" material so often ships with a thin COA, an unverifiable one, or none at all.

U.S. Food and Drug Administration. Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act: bulk substances must be accompanied by a valid certificate of analysis and manufactured by an FDA-registered establishment. View study

So when you read a COA from a prescription peptide, you are reading a document the pharmacy was required to obtain, tied to a manufacturer the FDA can identify. That is a different category of paperwork from a screenshot pasted onto a product page. It is the same distinction we draw on the clinical side in our research vs prescription peptides comparison: the pharmacy guarantees the vial, the provider guarantees the decision, and a real peptide service gives you both.

Frequently Asked Questions

Reviewed by Dr. Cory Mellon, MD · Last reviewed June 2026